India and the United States have reaffirmed their commitment to strengthening bilateral cooperation against drug trafficking during the second India-US Drug Policy Executive Working Group Meeting, held in New Delhi on November 2-3.
Hosted by the Narcotics Control Bureau (NCB) under the Ministry of Home Affairs, the meeting brought together policymakers and law enforcement officials from both countries.
The Indian delegation was led by NCB Director General Anurag Garg, while the US delegation was headed by Debbie Seguin, Acting Deputy Director of the Office of National Drug Control Policy (ONDCP).
The discussions reviewed existing cooperation and identified priorities, including intelligence sharing, coordinated law enforcement, precursor chemical control, pharmaceutical supply chain integrity and drug demand reduction.
Garg highlighted India’s Vision Roadmap 2026–2029, which focuses on network-based investigations, financial probes, prevention and rehabilitation.
US Drug Czar Sara Carter stressed cross-border partnerships to disrupt trafficking networks and prevent the diversion of synthetic drugs and chemical precursors.
US Ambassador to India Sergio Gor also highlighted operational cooperation between the two countries.
Building on the first meeting held in Washington, DC, in January 2026, both sides discussed emerging threats and welcomed initiatives including Operations MedMax and WIPE, alongside India’s Voluntary Code of Conduct to prevent precursor diversion.
The delegations agreed to strengthen institutional engagement, intelligence exchange and the sharing of law enforcement practices to address narcotics threats and protect communities.
